Article Information
History
- December 11, 2023.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY 4.0 International license.
Author Information
- Mark A.M. Van Den Elshout1,*,#,
- Eline Wijstma1,*,
- Anders Boyd1,2,5,7,
- Vita Jongen1,2,
- Liza Coyer1,
- Peter L. Anderson3,
- Udi Davidovich1,4,
- Henry J.C. De Vries1,5,6,
- Maria Prins1,5,7,
- Maarten F. Schim Van Der Loeff1,5,7,**,
- Elske Hoornenborg1,** and
- the Amsterdam PrEP Project team in the HIV Transmission Elimination AMsterdam Initiative (H-TEAM)
- 1Department of Infectious Diseases, Public Health Service of Amsterdam, Amsterdam, the Netherlands
- 2Stichting hiv monitoring, Amsterdam, the Netherlands
- 3Department of Pharmaceutical Sciences, University of Colorado Anschutz Medical Campus, Aurora, CO, USA
- 4Department of Social Psychology, University of Amsterdam, Amsterdam, the Netherlands
- 5Amsterdam UMC location University of Amsterdam, Amsterdam institute for Infection & Immunity (AII), Meibergdreef 9, Amsterdam, the Netherlands
- 6Amsterdam UMC location University of Amsterdam, Department of Dermatology, Meibergdreef 9, Amsterdam, the Netherlands
- 7Amsterdam UMC location University of Amsterdam, Department of Infectious Diseases, Meibergdreef 9, Amsterdam, the Netherlands
- ↵#Corresponding author: Mark A.M. van den Elshout, MD, Nieuwe Achtergracht 100, 1018 WT Amsterdam, the Netherlands Phone: +31 20 555 9384, Email: mvdelshout{at}ggd.amsterdam.nl